.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:400,h:400,cg:true)
Bioequivalence (BE) is a term in pharmacokinetics used to assess the expected biological similarity between two drug preparations. When two drug products are said to be bioequivalent, it means they are expected to be the same in terms of efficacy and clinical results.
Bioequivalence studies are an essential requirement for the approval of Generic Drugs. They ensure that the generic version of the medicine:
Yes, these studies are conducted under strict medical supervision and are regulated by national health authorities (such as the FDA or local regulatory bodies). They are usually conducted on healthy volunteers to ensure that the results are accurate and not affected by other medical conditions.
Clinical trials are research studies performed on humans aimed at evaluating medical, surgical, or behavioral interventions. They are the primary way researchers discover if a new treatment (such as a new drug) is safe and effective for human use.
Patient safety is the top priority. Every trial must be approved and monitored by an Institutional Review Board (IRB) or an Ethics Committee to ensure that risks are minimized and that the potential benefits justify the participation.